At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...